Financhill
Sell
36

HIMS Quote, Financials, Valuation and Earnings

Last price:
$29.14
Seasonality move :
-0.33%
Day range:
$28.90 - $31.89
52-week range:
$11.20 - $72.98
Dividend yield:
0%
P/E ratio:
53.96x
P/S ratio:
4.67x
P/B ratio:
13.58x
Volume:
20.9M
Avg. volume:
31.8M
1-year change:
88.36%
Market cap:
$6.5B
Revenue:
$1.5B
EPS (TTM):
$0.54

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HIMS
Hims & Hers Health
$564.9M $0.24 92.4% 312.9% $44.16
EWCZ
European Wax Center
$57.9M $0.11 -3.47% -6.25% $6.31
GROV
Grove Collaborative Holdings
$47.4M -$0.09 -12.21% -60% $2.50
KVUE
Kenvue
$4B $0.29 -5.39% 54.63% $24.25
SKIN
The Beauty Health
$75.3M -$0.09 -21.04% -30% $1.58
SNBH
Sentient Brands Holdings
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HIMS
Hims & Hers Health
$29.14 $44.16 $6.5B 53.96x $0.00 0% 4.67x
EWCZ
European Wax Center
$3.91 $6.31 $169.5M 17.46x $0.00 0% 0.84x
GROV
Grove Collaborative Holdings
$1.34 $2.50 $53.8M -- $0.00 0% 0.24x
KVUE
Kenvue
$23.70 $24.25 $45.3B 44.72x $0.21 3.44% 2.95x
SKIN
The Beauty Health
$1.32 $1.58 $165.3M -- $0.00 0% 0.55x
SNBH
Sentient Brands Holdings
$0.04 -- $2.5M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HIMS
Hims & Hers Health
-- 7.338 -- 1.38x
EWCZ
European Wax Center
85.49% -1.418 115.69% 1.58x
GROV
Grove Collaborative Holdings
31.62% 1.822 9.37% 0.73x
KVUE
Kenvue
46.77% 1.501 20.79% 0.65x
SKIN
The Beauty Health
91.42% 0.014 278% 5.85x
SNBH
Sentient Brands Holdings
-- -1.395 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HIMS
Hims & Hers Health
$369.5M $18.6M 32.03% 32.03% 3.87% $59.5M
EWCZ
European Wax Center
$37M $12.8M 2.18% 9.76% 16.01% $16.3M
GROV
Grove Collaborative Holdings
$25.9M -$8.3M -39.61% -154.22% -22.3% -$95K
KVUE
Kenvue
$2.1B $557M 5.43% 9.84% 13.49% $661M
SKIN
The Beauty Health
$52.3M -$7.2M -4.33% -47.95% -11.09% $15.6M
SNBH
Sentient Brands Holdings
-- -$78.3K -- -- -- -$200

Hims & Hers Health vs. Competitors

  • Which has Higher Returns HIMS or EWCZ?

    European Wax Center has a net margin of 5.41% compared to Hims & Hers Health's net margin of 3.96%. Hims & Hers Health's return on equity of 32.03% beat European Wax Center's return on equity of 9.76%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    76.81% $0.11 $476.7M
    EWCZ
    European Wax Center
    74.34% $0.04 $468.8M
  • What do Analysts Say About HIMS or EWCZ?

    Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 51.55%. On the other hand European Wax Center has an analysts' consensus of $6.31 which suggests that it could grow by 61.45%. Given that European Wax Center has higher upside potential than Hims & Hers Health, analysts believe European Wax Center is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 7 1
    EWCZ
    European Wax Center
    3 5 1
  • Is HIMS or EWCZ More Risky?

    Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or EWCZ?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HIMS or EWCZ?

    Hims & Hers Health quarterly revenues are $481.1M, which are larger than European Wax Center quarterly revenues of $49.7M. Hims & Hers Health's net income of $26M is higher than European Wax Center's net income of $2M. Notably, Hims & Hers Health's price-to-earnings ratio is 53.96x while European Wax Center's PE ratio is 17.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 4.67x versus 0.84x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    4.67x 53.96x $481.1M $26M
    EWCZ
    European Wax Center
    0.84x 17.46x $49.7M $2M
  • Which has Higher Returns HIMS or GROV?

    Grove Collaborative Holdings has a net margin of 5.41% compared to Hims & Hers Health's net margin of -25.53%. Hims & Hers Health's return on equity of 32.03% beat Grove Collaborative Holdings's return on equity of -154.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    76.81% $0.11 $476.7M
    GROV
    Grove Collaborative Holdings
    52.41% -$0.34 $23.7M
  • What do Analysts Say About HIMS or GROV?

    Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 51.55%. On the other hand Grove Collaborative Holdings has an analysts' consensus of $2.50 which suggests that it could grow by 86.57%. Given that Grove Collaborative Holdings has higher upside potential than Hims & Hers Health, analysts believe Grove Collaborative Holdings is more attractive than Hims & Hers Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 7 1
    GROV
    Grove Collaborative Holdings
    2 0 0
  • Is HIMS or GROV More Risky?

    Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Grove Collaborative Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or GROV?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. Grove Collaborative Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or GROV?

    Hims & Hers Health quarterly revenues are $481.1M, which are larger than Grove Collaborative Holdings quarterly revenues of $49.5M. Hims & Hers Health's net income of $26M is higher than Grove Collaborative Holdings's net income of -$12.6M. Notably, Hims & Hers Health's price-to-earnings ratio is 53.96x while Grove Collaborative Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 4.67x versus 0.24x for Grove Collaborative Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    4.67x 53.96x $481.1M $26M
    GROV
    Grove Collaborative Holdings
    0.24x -- $49.5M -$12.6M
  • Which has Higher Returns HIMS or KVUE?

    Kenvue has a net margin of 5.41% compared to Hims & Hers Health's net margin of 8%. Hims & Hers Health's return on equity of 32.03% beat Kenvue's return on equity of 9.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    76.81% $0.11 $476.7M
    KVUE
    Kenvue
    56.53% $0.15 $18.2B
  • What do Analysts Say About HIMS or KVUE?

    Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 51.55%. On the other hand Kenvue has an analysts' consensus of $24.25 which suggests that it could grow by 2.33%. Given that Hims & Hers Health has higher upside potential than Kenvue, analysts believe Hims & Hers Health is more attractive than Kenvue.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 7 1
    KVUE
    Kenvue
    3 13 0
  • Is HIMS or KVUE More Risky?

    Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or KVUE?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.44% to investors and pays a quarterly dividend of $0.21 per share. Hims & Hers Health pays -- of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or KVUE?

    Hims & Hers Health quarterly revenues are $481.1M, which are smaller than Kenvue quarterly revenues of $3.7B. Hims & Hers Health's net income of $26M is lower than Kenvue's net income of $293M. Notably, Hims & Hers Health's price-to-earnings ratio is 53.96x while Kenvue's PE ratio is 44.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 4.67x versus 2.95x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    4.67x 53.96x $481.1M $26M
    KVUE
    Kenvue
    2.95x 44.72x $3.7B $293M
  • Which has Higher Returns HIMS or SKIN?

    The Beauty Health has a net margin of 5.41% compared to Hims & Hers Health's net margin of -12.37%. Hims & Hers Health's return on equity of 32.03% beat The Beauty Health's return on equity of -47.95%.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    76.81% $0.11 $476.7M
    SKIN
    The Beauty Health
    62.69% -$0.08 $604M
  • What do Analysts Say About HIMS or SKIN?

    Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 51.55%. On the other hand The Beauty Health has an analysts' consensus of $1.58 which suggests that it could grow by 19.32%. Given that Hims & Hers Health has higher upside potential than The Beauty Health, analysts believe Hims & Hers Health is more attractive than The Beauty Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 7 1
    SKIN
    The Beauty Health
    0 7 0
  • Is HIMS or SKIN More Risky?

    Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or SKIN?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or SKIN?

    Hims & Hers Health quarterly revenues are $481.1M, which are larger than The Beauty Health quarterly revenues of $83.5M. Hims & Hers Health's net income of $26M is higher than The Beauty Health's net income of -$10.3M. Notably, Hims & Hers Health's price-to-earnings ratio is 53.96x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 4.67x versus 0.55x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    4.67x 53.96x $481.1M $26M
    SKIN
    The Beauty Health
    0.55x -- $83.5M -$10.3M
  • Which has Higher Returns HIMS or SNBH?

    Sentient Brands Holdings has a net margin of 5.41% compared to Hims & Hers Health's net margin of --. Hims & Hers Health's return on equity of 32.03% beat Sentient Brands Holdings's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HIMS
    Hims & Hers Health
    76.81% $0.11 $476.7M
    SNBH
    Sentient Brands Holdings
    -- -$0.01 --
  • What do Analysts Say About HIMS or SNBH?

    Hims & Hers Health has a consensus price target of $44.16, signalling upside risk potential of 51.55%. On the other hand Sentient Brands Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Hims & Hers Health has higher upside potential than Sentient Brands Holdings, analysts believe Hims & Hers Health is more attractive than Sentient Brands Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    HIMS
    Hims & Hers Health
    4 7 1
    SNBH
    Sentient Brands Holdings
    0 0 0
  • Is HIMS or SNBH More Risky?

    Hims & Hers Health has a beta of 1.368, which suggesting that the stock is 36.817% more volatile than S&P 500. In comparison Sentient Brands Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HIMS or SNBH?

    Hims & Hers Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sentient Brands Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hims & Hers Health pays -- of its earnings as a dividend. Sentient Brands Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HIMS or SNBH?

    Hims & Hers Health quarterly revenues are $481.1M, which are larger than Sentient Brands Holdings quarterly revenues of --. Hims & Hers Health's net income of $26M is higher than Sentient Brands Holdings's net income of -$291.8K. Notably, Hims & Hers Health's price-to-earnings ratio is 53.96x while Sentient Brands Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hims & Hers Health is 4.67x versus -- for Sentient Brands Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HIMS
    Hims & Hers Health
    4.67x 53.96x $481.1M $26M
    SNBH
    Sentient Brands Holdings
    -- -- -- -$291.8K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Buffett Sell the S&P 500?
Why Did Buffett Sell the S&P 500?

Warren Buffett has always been an advocate of investing in…

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

What Stocks Did Warren Buffett Just Buy?
What Stocks Did Warren Buffett Just Buy?

In Q4 of last year, Warren Buffett added to or…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock